nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP2D6—Lomustine—brain cancer	0.117	0.253	CbGbCtD
Nefazodone—CYP2D6—Hydroxyurea—brain cancer	0.0886	0.192	CbGbCtD
Nefazodone—CYP3A4—Temozolomide—brain cancer	0.0875	0.19	CbGbCtD
Nefazodone—CYP3A4—Lomustine—brain cancer	0.0744	0.161	CbGbCtD
Nefazodone—CYP3A5—Etoposide—brain cancer	0.0461	0.0999	CbGbCtD
Nefazodone—ABCB1—Etoposide—brain cancer	0.03	0.065	CbGbCtD
Nefazodone—HTR2C—choroid plexus—brain cancer	0.0213	0.111	CbGeAlD
Nefazodone—CYP3A4—Etoposide—brain cancer	0.018	0.039	CbGbCtD
Nefazodone—HTR2A—choroid plexus—brain cancer	0.0107	0.0558	CbGeAlD
Nefazodone—SLC6A3—telencephalic ventricle—brain cancer	0.00645	0.0337	CbGeAlD
Nefazodone—HTR2C—telencephalic ventricle—brain cancer	0.00624	0.0326	CbGeAlD
Nefazodone—Trifluoperazine—S100A4—brain cancer	0.00564	0.877	CrCbGaD
Nefazodone—HTR2A—trigeminal nerve—brain cancer	0.0054	0.0282	CbGeAlD
Nefazodone—HTR2A—cerebellar cortex—brain cancer	0.00538	0.0281	CbGeAlD
Nefazodone—HTR1A—telencephalic ventricle—brain cancer	0.00525	0.0275	CbGeAlD
Nefazodone—HTR2A—vein—brain cancer	0.00488	0.0255	CbGeAlD
Nefazodone—SLC6A3—ganglion—brain cancer	0.00402	0.021	CbGeAlD
Nefazodone—HTR2C—ganglion—brain cancer	0.00388	0.0203	CbGeAlD
Nefazodone—HTR2A—cranial nerve—brain cancer	0.00385	0.0201	CbGeAlD
Nefazodone—HTR2A—pons—brain cancer	0.0038	0.0199	CbGeAlD
Nefazodone—SLC6A4—ganglion—brain cancer	0.00368	0.0192	CbGeAlD
Nefazodone—HTR1A—ganglion—brain cancer	0.00327	0.0171	CbGeAlD
Nefazodone—SLC6A2—ganglion—brain cancer	0.00324	0.0169	CbGeAlD
Nefazodone—HTR2A—telencephalic ventricle—brain cancer	0.00313	0.0164	CbGeAlD
Nefazodone—SLC6A3—hindbrain—brain cancer	0.00305	0.0159	CbGeAlD
Nefazodone—SLC6A4—hindbrain—brain cancer	0.00279	0.0146	CbGeAlD
Nefazodone—HTR2A—pineal body—brain cancer	0.00272	0.0142	CbGeAlD
Nefazodone—HTR1A—hindbrain—brain cancer	0.00248	0.013	CbGeAlD
Nefazodone—ADRA1A—hindbrain—brain cancer	0.00229	0.0119	CbGeAlD
Nefazodone—HTR2A—ganglion—brain cancer	0.00195	0.0102	CbGeAlD
Nefazodone—SLC6A3—brainstem—brain cancer	0.00175	0.00913	CbGeAlD
Nefazodone—HTR2C—brainstem—brain cancer	0.00169	0.00882	CbGeAlD
Nefazodone—HTR2A—endothelium—brain cancer	0.00168	0.00878	CbGeAlD
Nefazodone—CYP3A7—endocrine gland—brain cancer	0.00166	0.00869	CbGeAlD
Nefazodone—SLC6A4—brainstem—brain cancer	0.0016	0.00837	CbGeAlD
Nefazodone—SLC6A3—telencephalon—brain cancer	0.00155	0.0081	CbGeAlD
Nefazodone—HTR2A—blood vessel—brain cancer	0.00155	0.0081	CbGeAlD
Nefazodone—HTR2C—telencephalon—brain cancer	0.0015	0.00783	CbGeAlD
Nefazodone—HTR2A—hindbrain—brain cancer	0.00148	0.00772	CbGeAlD
Nefazodone—HTR1A—brainstem—brain cancer	0.00142	0.00743	CbGeAlD
Nefazodone—SLC6A4—telencephalon—brain cancer	0.00142	0.00742	CbGeAlD
Nefazodone—SLC6A2—brainstem—brain cancer	0.00141	0.00737	CbGeAlD
Nefazodone—CYP2D6—hindbrain—brain cancer	0.00135	0.00704	CbGeAlD
Nefazodone—ADRA1A—brainstem—brain cancer	0.00131	0.00685	CbGeAlD
Nefazodone—ADRA1B—head—brain cancer	0.00129	0.00673	CbGeAlD
Nefazodone—HTR1A—telencephalon—brain cancer	0.00126	0.00659	CbGeAlD
Nefazodone—SLC6A2—telencephalon—brain cancer	0.00125	0.00654	CbGeAlD
Nefazodone—HTR2C—medulla oblongata—brain cancer	0.00118	0.00615	CbGeAlD
Nefazodone—ADRA1B—central nervous system—brain cancer	0.00118	0.00615	CbGeAlD
Nefazodone—ADRA1A—telencephalon—brain cancer	0.00116	0.00608	CbGeAlD
Nefazodone—SLC6A3—midbrain—brain cancer	0.00111	0.00582	CbGeAlD
Nefazodone—SLC6A3—spinal cord—brain cancer	0.00109	0.00568	CbGeAlD
Nefazodone—HTR2C—midbrain—brain cancer	0.00108	0.00562	CbGeAlD
Nefazodone—HTR2C—spinal cord—brain cancer	0.00105	0.00549	CbGeAlD
Nefazodone—SLC6A2—gonad—brain cancer	0.00104	0.00546	CbGeAlD
Nefazodone—SLC6A4—midbrain—brain cancer	0.00102	0.00533	CbGeAlD
Nefazodone—ABCB1—blood vessel—brain cancer	0.00102	0.00531	CbGeAlD
Nefazodone—SLC6A4—spinal cord—brain cancer	0.000995	0.0052	CbGeAlD
Nefazodone—SLC6A2—medulla oblongata—brain cancer	0.000982	0.00514	CbGeAlD
Nefazodone—SLC6A3—head—brain cancer	0.000965	0.00504	CbGeAlD
Nefazodone—ADRA1B—brain—brain cancer	0.000934	0.00488	CbGeAlD
Nefazodone—HTR2C—head—brain cancer	0.000933	0.00488	CbGeAlD
Nefazodone—HTR1A—midbrain—brain cancer	0.000906	0.00473	CbGeAlD
Nefazodone—SLC6A4—endocrine gland—brain cancer	0.000896	0.00468	CbGeAlD
Nefazodone—SLC6A4—head—brain cancer	0.000884	0.00462	CbGeAlD
Nefazodone—ADRA2A—telencephalon—brain cancer	0.000884	0.00462	CbGeAlD
Nefazodone—HTR1A—spinal cord—brain cancer	0.000884	0.00462	CbGeAlD
Nefazodone—SLC6A3—central nervous system—brain cancer	0.000881	0.0046	CbGeAlD
Nefazodone—SLC6A3—cerebellum—brain cancer	0.000861	0.0045	CbGeAlD
Nefazodone—HTR2C—central nervous system—brain cancer	0.000852	0.00445	CbGeAlD
Nefazodone—HTR2A—brainstem—brain cancer	0.000847	0.00443	CbGeAlD
Nefazodone—Cough—Procarbazine—brain cancer	0.000813	0.00282	CcSEcCtD
Nefazodone—Dysphagia—Temozolomide—brain cancer	0.000809	0.00281	CcSEcCtD
Nefazodone—Convulsion—Procarbazine—brain cancer	0.000808	0.0028	CcSEcCtD
Nefazodone—SLC6A4—central nervous system—brain cancer	0.000807	0.00422	CbGeAlD
Nefazodone—Hypertension—Procarbazine—brain cancer	0.000805	0.00279	CcSEcCtD
Nefazodone—HTR1A—endocrine gland—brain cancer	0.000795	0.00416	CbGeAlD
Nefazodone—Myalgia—Procarbazine—brain cancer	0.000794	0.00275	CcSEcCtD
Nefazodone—Arthralgia—Procarbazine—brain cancer	0.000794	0.00275	CcSEcCtD
Nefazodone—Perphenazine—CYP2C9—brain cancer	0.000793	0.123	CrCbGaD
Nefazodone—Anxiety—Procarbazine—brain cancer	0.000791	0.00274	CcSEcCtD
Nefazodone—SLC6A2—endocrine gland—brain cancer	0.000789	0.00412	CbGeAlD
Nefazodone—HTR1A—head—brain cancer	0.000785	0.0041	CbGeAlD
Nefazodone—SLC6A2—head—brain cancer	0.000779	0.00407	CbGeAlD
Nefazodone—Bronchitis—Temozolomide—brain cancer	0.000778	0.0027	CcSEcCtD
Nefazodone—Dry mouth—Procarbazine—brain cancer	0.000776	0.00269	CcSEcCtD
Nefazodone—CYP2D6—brainstem—brain cancer	0.000771	0.00403	CbGeAlD
Nefazodone—Confusional state—Procarbazine—brain cancer	0.000767	0.00266	CcSEcCtD
Nefazodone—Vomiting—Lomustine—brain cancer	0.000762	0.00264	CcSEcCtD
Nefazodone—Oedema—Procarbazine—brain cancer	0.000761	0.00264	CcSEcCtD
Nefazodone—Dysuria—Temozolomide—brain cancer	0.000756	0.00262	CcSEcCtD
Nefazodone—Infection—Procarbazine—brain cancer	0.000756	0.00262	CcSEcCtD
Nefazodone—HTR2A—telencephalon—brain cancer	0.000752	0.00393	CbGeAlD
Nefazodone—Pneumonia—Carmustine—brain cancer	0.000751	0.0026	CcSEcCtD
Nefazodone—Shock—Procarbazine—brain cancer	0.000748	0.0026	CcSEcCtD
Nefazodone—Pollakiuria—Temozolomide—brain cancer	0.000747	0.00259	CcSEcCtD
Nefazodone—Erectile dysfunction—Temozolomide—brain cancer	0.000745	0.00258	CcSEcCtD
Nefazodone—Thrombocytopenia—Procarbazine—brain cancer	0.000745	0.00258	CcSEcCtD
Nefazodone—Chills—Hydroxyurea—brain cancer	0.000744	0.00258	CcSEcCtD
Nefazodone—Tachycardia—Procarbazine—brain cancer	0.000742	0.00258	CcSEcCtD
Nefazodone—Photosensitivity reaction—Temozolomide—brain cancer	0.000738	0.00256	CcSEcCtD
Nefazodone—ADRA2A—gonad—brain cancer	0.000738	0.00386	CbGeAlD
Nefazodone—Weight increased—Temozolomide—brain cancer	0.000736	0.00255	CcSEcCtD
Nefazodone—Hyperhidrosis—Procarbazine—brain cancer	0.000735	0.00255	CcSEcCtD
Nefazodone—ADRA1A—endocrine gland—brain cancer	0.000733	0.00383	CbGeAlD
Nefazodone—Alopecia—Hydroxyurea—brain cancer	0.000732	0.00254	CcSEcCtD
Nefazodone—Weight decreased—Temozolomide—brain cancer	0.000732	0.00254	CcSEcCtD
Nefazodone—Stomatitis—Carmustine—brain cancer	0.000727	0.00252	CcSEcCtD
Nefazodone—Urinary tract infection—Carmustine—brain cancer	0.000725	0.00252	CcSEcCtD
Nefazodone—Pneumonia—Temozolomide—brain cancer	0.000725	0.00252	CcSEcCtD
Nefazodone—Anorexia—Procarbazine—brain cancer	0.000725	0.00252	CcSEcCtD
Nefazodone—ADRA1A—head—brain cancer	0.000724	0.00378	CbGeAlD
Nefazodone—ADRA2A—pituitary gland—brain cancer	0.00072	0.00376	CbGeAlD
Nefazodone—HTR1A—central nervous system—brain cancer	0.000717	0.00375	CbGeAlD
Nefazodone—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000715	0.00248	CcSEcCtD
Nefazodone—Nausea—Lomustine—brain cancer	0.000712	0.00247	CcSEcCtD
Nefazodone—Hypotension—Procarbazine—brain cancer	0.000711	0.00247	CcSEcCtD
Nefazodone—SLC6A2—central nervous system—brain cancer	0.000711	0.00372	CbGeAlD
Nefazodone—Stomatitis—Temozolomide—brain cancer	0.000703	0.00244	CcSEcCtD
Nefazodone—Urinary tract infection—Temozolomide—brain cancer	0.000701	0.00243	CcSEcCtD
Nefazodone—HTR1A—cerebellum—brain cancer	0.000701	0.00366	CbGeAlD
Nefazodone—SLC6A3—brain—brain cancer	0.000699	0.00366	CbGeAlD
Nefazodone—ADRA2A—medulla oblongata—brain cancer	0.000694	0.00363	CbGeAlD
Nefazodone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000693	0.0024	CcSEcCtD
Nefazodone—Insomnia—Procarbazine—brain cancer	0.000688	0.00239	CcSEcCtD
Nefazodone—CYP2D6—telencephalon—brain cancer	0.000685	0.00358	CbGeAlD
Nefazodone—Paraesthesia—Procarbazine—brain cancer	0.000683	0.00237	CcSEcCtD
Nefazodone—Sinusitis—Temozolomide—brain cancer	0.000677	0.00235	CcSEcCtD
Nefazodone—Somnolence—Procarbazine—brain cancer	0.000676	0.00235	CcSEcCtD
Nefazodone—HTR2C—brain—brain cancer	0.000676	0.00353	CbGeAlD
Nefazodone—Cramp muscle—Etoposide—brain cancer	0.000674	0.00234	CcSEcCtD
Nefazodone—Haemoglobin—Carmustine—brain cancer	0.000673	0.00234	CcSEcCtD
Nefazodone—Haemorrhage—Carmustine—brain cancer	0.00067	0.00232	CcSEcCtD
Nefazodone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000669	0.00232	CcSEcCtD
Nefazodone—Anaemia—Hydroxyurea—brain cancer	0.000667	0.00231	CcSEcCtD
Nefazodone—Hallucination—Carmustine—brain cancer	0.000667	0.00231	CcSEcCtD
Nefazodone—Hypoaesthesia—Carmustine—brain cancer	0.000667	0.00231	CcSEcCtD
Nefazodone—Decreased appetite—Procarbazine—brain cancer	0.000661	0.00229	CcSEcCtD
Nefazodone—ADRA1A—central nervous system—brain cancer	0.000661	0.00345	CbGeAlD
Nefazodone—Alanine aminotransferase increased—Etoposide—brain cancer	0.00066	0.00229	CcSEcCtD
Nefazodone—Oedema peripheral—Carmustine—brain cancer	0.00066	0.00229	CcSEcCtD
Nefazodone—Haemoglobin—Temozolomide—brain cancer	0.000651	0.00226	CcSEcCtD
Nefazodone—Malaise—Hydroxyurea—brain cancer	0.000651	0.00226	CcSEcCtD
Nefazodone—Pain—Procarbazine—brain cancer	0.000651	0.00226	CcSEcCtD
Nefazodone—Constipation—Procarbazine—brain cancer	0.000651	0.00226	CcSEcCtD
Nefazodone—Haemorrhage—Temozolomide—brain cancer	0.000647	0.00225	CcSEcCtD
Nefazodone—Hepatitis—Temozolomide—brain cancer	0.000647	0.00225	CcSEcCtD
Nefazodone—Dysphagia—Etoposide—brain cancer	0.000647	0.00225	CcSEcCtD
Nefazodone—ADRA1A—cerebellum—brain cancer	0.000646	0.00338	CbGeAlD
Nefazodone—Leukopenia—Hydroxyurea—brain cancer	0.000646	0.00224	CcSEcCtD
Nefazodone—Visual impairment—Carmustine—brain cancer	0.000646	0.00224	CcSEcCtD
Nefazodone—Hypoaesthesia—Temozolomide—brain cancer	0.000644	0.00223	CcSEcCtD
Nefazodone—Hallucination—Temozolomide—brain cancer	0.000644	0.00223	CcSEcCtD
Nefazodone—Pharyngitis—Temozolomide—brain cancer	0.000642	0.00223	CcSEcCtD
Nefazodone—SLC6A4—brain—brain cancer	0.000641	0.00335	CbGeAlD
Nefazodone—Oedema peripheral—Temozolomide—brain cancer	0.000638	0.00221	CcSEcCtD
Nefazodone—ADRA2A—midbrain—brain cancer	0.000635	0.00332	CbGeAlD
Nefazodone—HTR2A—gonad—brain cancer	0.000627	0.00328	CbGeAlD
Nefazodone—Feeling abnormal—Procarbazine—brain cancer	0.000627	0.00217	CcSEcCtD
Nefazodone—Convulsion—Hydroxyurea—brain cancer	0.000625	0.00217	CcSEcCtD
Nefazodone—Visual impairment—Temozolomide—brain cancer	0.000624	0.00216	CcSEcCtD
Nefazodone—Gastrointestinal pain—Procarbazine—brain cancer	0.000622	0.00216	CcSEcCtD
Nefazodone—Flushing—Carmustine—brain cancer	0.000622	0.00216	CcSEcCtD
Nefazodone—ADRA2A—spinal cord—brain cancer	0.000619	0.00324	CbGeAlD
Nefazodone—Erythema multiforme—Temozolomide—brain cancer	0.000612	0.00212	CcSEcCtD
Nefazodone—HTR2A—pituitary gland—brain cancer	0.000612	0.0032	CbGeAlD
Nefazodone—Discomfort—Hydroxyurea—brain cancer	0.000607	0.00211	CcSEcCtD
Nefazodone—Urticaria—Procarbazine—brain cancer	0.000604	0.0021	CcSEcCtD
Nefazodone—Tinnitus—Temozolomide—brain cancer	0.000604	0.00209	CcSEcCtD
Nefazodone—Abdominal pain—Procarbazine—brain cancer	0.000601	0.00209	CcSEcCtD
Nefazodone—Body temperature increased—Procarbazine—brain cancer	0.000601	0.00209	CcSEcCtD
Nefazodone—Flushing—Temozolomide—brain cancer	0.000601	0.00208	CcSEcCtD
Nefazodone—Alopecia—Carmustine—brain cancer	0.000592	0.00205	CcSEcCtD
Nefazodone—HTR2A—medulla oblongata—brain cancer	0.00059	0.00309	CbGeAlD
Nefazodone—Oedema—Hydroxyurea—brain cancer	0.000589	0.00204	CcSEcCtD
Nefazodone—Infection—Hydroxyurea—brain cancer	0.000585	0.00203	CcSEcCtD
Nefazodone—CYP3A5—endocrine gland—brain cancer	0.000585	0.00306	CbGeAlD
Nefazodone—Chills—Temozolomide—brain cancer	0.000581	0.00202	CcSEcCtD
Nefazodone—Pneumonia—Etoposide—brain cancer	0.00058	0.00201	CcSEcCtD
Nefazodone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000576	0.002	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000572	0.00198	CcSEcCtD
Nefazodone—Alopecia—Temozolomide—brain cancer	0.000572	0.00198	CcSEcCtD
Nefazodone—HTR1A—brain—brain cancer	0.000569	0.00297	CbGeAlD
Nefazodone—SLC6A2—brain—brain cancer	0.000564	0.00295	CbGeAlD
Nefazodone—Back pain—Carmustine—brain cancer	0.000564	0.00196	CcSEcCtD
Nefazodone—Stomatitis—Etoposide—brain cancer	0.000562	0.00195	CcSEcCtD
Nefazodone—Anorexia—Hydroxyurea—brain cancer	0.000561	0.00195	CcSEcCtD
Nefazodone—Hypersensitivity—Procarbazine—brain cancer	0.00056	0.00194	CcSEcCtD
Nefazodone—ADRA2A—endocrine gland—brain cancer	0.000557	0.00291	CbGeAlD
Nefazodone—Dysgeusia—Temozolomide—brain cancer	0.000552	0.00191	CcSEcCtD
Nefazodone—ADRA2A—head—brain cancer	0.00055	0.00288	CbGeAlD
Nefazodone—Vision blurred—Carmustine—brain cancer	0.00055	0.00191	CcSEcCtD
Nefazodone—Tremor—Carmustine—brain cancer	0.000546	0.0019	CcSEcCtD
Nefazodone—Asthenia—Procarbazine—brain cancer	0.000546	0.00189	CcSEcCtD
Nefazodone—Back pain—Temozolomide—brain cancer	0.000545	0.00189	CcSEcCtD
Nefazodone—HTR2A—midbrain—brain cancer	0.00054	0.00282	CbGeAlD
Nefazodone—Anaemia—Carmustine—brain cancer	0.000539	0.00187	CcSEcCtD
Nefazodone—Pruritus—Procarbazine—brain cancer	0.000538	0.00187	CcSEcCtD
Nefazodone—Agitation—Carmustine—brain cancer	0.000536	0.00186	CcSEcCtD
Nefazodone—Vision blurred—Temozolomide—brain cancer	0.000531	0.00184	CcSEcCtD
Nefazodone—Tremor—Temozolomide—brain cancer	0.000528	0.00183	CcSEcCtD
Nefazodone—HTR2A—spinal cord—brain cancer	0.000527	0.00275	CbGeAlD
Nefazodone—Dyspnoea—Hydroxyurea—brain cancer	0.000525	0.00182	CcSEcCtD
Nefazodone—ADRA1A—brain—brain cancer	0.000525	0.00274	CbGeAlD
Nefazodone—Somnolence—Hydroxyurea—brain cancer	0.000523	0.00182	CcSEcCtD
Nefazodone—Ill-defined disorder—Temozolomide—brain cancer	0.000523	0.00181	CcSEcCtD
Nefazodone—Leukopenia—Carmustine—brain cancer	0.000522	0.00181	CcSEcCtD
Nefazodone—Anaemia—Temozolomide—brain cancer	0.000521	0.00181	CcSEcCtD
Nefazodone—Diarrhoea—Procarbazine—brain cancer	0.00052	0.00181	CcSEcCtD
Nefazodone—Dyspepsia—Hydroxyurea—brain cancer	0.000518	0.0018	CcSEcCtD
Nefazodone—Agitation—Temozolomide—brain cancer	0.000518	0.0018	CcSEcCtD
Nefazodone—Hypoaesthesia—Etoposide—brain cancer	0.000515	0.00179	CcSEcCtD
Nefazodone—Angioedema—Temozolomide—brain cancer	0.000515	0.00179	CcSEcCtD
Nefazodone—Decreased appetite—Hydroxyurea—brain cancer	0.000512	0.00178	CcSEcCtD
Nefazodone—Malaise—Temozolomide—brain cancer	0.000508	0.00176	CcSEcCtD
Nefazodone—Vertigo—Temozolomide—brain cancer	0.000506	0.00176	CcSEcCtD
Nefazodone—Convulsion—Carmustine—brain cancer	0.000505	0.00175	CcSEcCtD
Nefazodone—Leukopenia—Temozolomide—brain cancer	0.000504	0.00175	CcSEcCtD
Nefazodone—Hypertension—Carmustine—brain cancer	0.000503	0.00175	CcSEcCtD
Nefazodone—Pain—Hydroxyurea—brain cancer	0.000503	0.00175	CcSEcCtD
Nefazodone—Constipation—Hydroxyurea—brain cancer	0.000503	0.00175	CcSEcCtD
Nefazodone—Dizziness—Procarbazine—brain cancer	0.000503	0.00175	CcSEcCtD
Nefazodone—ADRA2A—central nervous system—brain cancer	0.000502	0.00263	CbGeAlD
Nefazodone—Palpitations—Temozolomide—brain cancer	0.000498	0.00173	CcSEcCtD
Nefazodone—Chest pain—Carmustine—brain cancer	0.000496	0.00172	CcSEcCtD
Nefazodone—Myalgia—Carmustine—brain cancer	0.000496	0.00172	CcSEcCtD
Nefazodone—Anxiety—Carmustine—brain cancer	0.000495	0.00172	CcSEcCtD
Nefazodone—ABCB1—telencephalon—brain cancer	0.000492	0.00257	CbGeAlD
Nefazodone—Cough—Temozolomide—brain cancer	0.000492	0.00171	CcSEcCtD
Nefazodone—ADRA2A—cerebellum—brain cancer	0.000491	0.00257	CbGeAlD
Nefazodone—Erythema multiforme—Etoposide—brain cancer	0.00049	0.0017	CcSEcCtD
Nefazodone—Convulsion—Temozolomide—brain cancer	0.000488	0.00169	CcSEcCtD
Nefazodone—Hypertension—Temozolomide—brain cancer	0.000487	0.00169	CcSEcCtD
Nefazodone—Feeling abnormal—Hydroxyurea—brain cancer	0.000485	0.00168	CcSEcCtD
Nefazodone—Vomiting—Procarbazine—brain cancer	0.000484	0.00168	CcSEcCtD
Nefazodone—Flushing—Etoposide—brain cancer	0.000481	0.00167	CcSEcCtD
Nefazodone—Confusional state—Carmustine—brain cancer	0.00048	0.00166	CcSEcCtD
Nefazodone—Arthralgia—Temozolomide—brain cancer	0.00048	0.00166	CcSEcCtD
Nefazodone—Myalgia—Temozolomide—brain cancer	0.00048	0.00166	CcSEcCtD
Nefazodone—Rash—Procarbazine—brain cancer	0.00048	0.00166	CcSEcCtD
Nefazodone—Dermatitis—Procarbazine—brain cancer	0.000479	0.00166	CcSEcCtD
Nefazodone—Anxiety—Temozolomide—brain cancer	0.000478	0.00166	CcSEcCtD
Nefazodone—Headache—Procarbazine—brain cancer	0.000477	0.00165	CcSEcCtD
Nefazodone—Oedema—Carmustine—brain cancer	0.000476	0.00165	CcSEcCtD
Nefazodone—HTR2A—endocrine gland—brain cancer	0.000474	0.00248	CbGeAlD
Nefazodone—Discomfort—Temozolomide—brain cancer	0.000474	0.00164	CcSEcCtD
Nefazodone—Infection—Carmustine—brain cancer	0.000473	0.00164	CcSEcCtD
Nefazodone—Dry mouth—Temozolomide—brain cancer	0.000469	0.00163	CcSEcCtD
Nefazodone—HTR2A—head—brain cancer	0.000468	0.00245	CbGeAlD
Nefazodone—Thrombocytopenia—Carmustine—brain cancer	0.000466	0.00162	CcSEcCtD
Nefazodone—Body temperature increased—Hydroxyurea—brain cancer	0.000465	0.00161	CcSEcCtD
Nefazodone—Chills—Etoposide—brain cancer	0.000465	0.00161	CcSEcCtD
Nefazodone—Tachycardia—Carmustine—brain cancer	0.000464	0.00161	CcSEcCtD
Nefazodone—Confusional state—Temozolomide—brain cancer	0.000464	0.00161	CcSEcCtD
Nefazodone—Oedema—Temozolomide—brain cancer	0.00046	0.0016	CcSEcCtD
Nefazodone—Anaphylactic shock—Temozolomide—brain cancer	0.00046	0.0016	CcSEcCtD
Nefazodone—Alopecia—Etoposide—brain cancer	0.000458	0.00159	CcSEcCtD
Nefazodone—Infection—Temozolomide—brain cancer	0.000457	0.00159	CcSEcCtD
Nefazodone—Anorexia—Carmustine—brain cancer	0.000454	0.00157	CcSEcCtD
Nefazodone—Nausea—Procarbazine—brain cancer	0.000452	0.00157	CcSEcCtD
Nefazodone—Thrombocytopenia—Temozolomide—brain cancer	0.00045	0.00156	CcSEcCtD
Nefazodone—Hypotension—Carmustine—brain cancer	0.000445	0.00154	CcSEcCtD
Nefazodone—Hyperhidrosis—Temozolomide—brain cancer	0.000445	0.00154	CcSEcCtD
Nefazodone—Dysgeusia—Etoposide—brain cancer	0.000442	0.00153	CcSEcCtD
Nefazodone—CYP3A4—endocrine gland—brain cancer	0.000439	0.00229	CbGeAlD
Nefazodone—Anorexia—Temozolomide—brain cancer	0.000438	0.00152	CcSEcCtD
Nefazodone—Back pain—Etoposide—brain cancer	0.000436	0.00151	CcSEcCtD
Nefazodone—Hypersensitivity—Hydroxyurea—brain cancer	0.000434	0.0015	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000434	0.0015	CcSEcCtD
Nefazodone—Muscle spasms—Etoposide—brain cancer	0.000434	0.0015	CcSEcCtD
Nefazodone—CYP2D6—endocrine gland—brain cancer	0.000432	0.00226	CbGeAlD
Nefazodone—Insomnia—Carmustine—brain cancer	0.00043	0.00149	CcSEcCtD
Nefazodone—Paraesthesia—Carmustine—brain cancer	0.000427	0.00148	CcSEcCtD
Nefazodone—HTR2A—central nervous system—brain cancer	0.000427	0.00223	CbGeAlD
Nefazodone—CYP2D6—head—brain cancer	0.000426	0.00223	CbGeAlD
Nefazodone—Dyspnoea—Carmustine—brain cancer	0.000424	0.00147	CcSEcCtD
Nefazodone—Somnolence—Carmustine—brain cancer	0.000423	0.00147	CcSEcCtD
Nefazodone—Asthenia—Hydroxyurea—brain cancer	0.000422	0.00147	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000419	0.00145	CcSEcCtD
Nefazodone—Ill-defined disorder—Etoposide—brain cancer	0.000418	0.00145	CcSEcCtD
Nefazodone—HTR2A—cerebellum—brain cancer	0.000418	0.00218	CbGeAlD
Nefazodone—Anaemia—Etoposide—brain cancer	0.000417	0.00145	CcSEcCtD
Nefazodone—Insomnia—Temozolomide—brain cancer	0.000416	0.00144	CcSEcCtD
Nefazodone—Decreased appetite—Carmustine—brain cancer	0.000414	0.00144	CcSEcCtD
Nefazodone—Paraesthesia—Temozolomide—brain cancer	0.000413	0.00143	CcSEcCtD
Nefazodone—ABCB1—gonad—brain cancer	0.000411	0.00215	CbGeAlD
Nefazodone—Dyspnoea—Temozolomide—brain cancer	0.00041	0.00142	CcSEcCtD
Nefazodone—Somnolence—Temozolomide—brain cancer	0.000409	0.00142	CcSEcCtD
Nefazodone—Constipation—Carmustine—brain cancer	0.000407	0.00141	CcSEcCtD
Nefazodone—Pain—Carmustine—brain cancer	0.000407	0.00141	CcSEcCtD
Nefazodone—Malaise—Etoposide—brain cancer	0.000407	0.00141	CcSEcCtD
Nefazodone—Vertigo—Etoposide—brain cancer	0.000405	0.00141	CcSEcCtD
Nefazodone—Dyspepsia—Temozolomide—brain cancer	0.000405	0.0014	CcSEcCtD
Nefazodone—Leukopenia—Etoposide—brain cancer	0.000404	0.0014	CcSEcCtD
Nefazodone—Diarrhoea—Hydroxyurea—brain cancer	0.000403	0.0014	CcSEcCtD
Nefazodone—ABCB1—pituitary gland—brain cancer	0.000401	0.0021	CbGeAlD
Nefazodone—Decreased appetite—Temozolomide—brain cancer	0.0004	0.00139	CcSEcCtD
Nefazodone—ADRA2A—brain—brain cancer	0.000399	0.00208	CbGeAlD
Nefazodone—Loss of consciousness—Etoposide—brain cancer	0.000396	0.00138	CcSEcCtD
Nefazodone—CYP3A4—central nervous system—brain cancer	0.000395	0.00207	CbGeAlD
Nefazodone—Cough—Etoposide—brain cancer	0.000393	0.00137	CcSEcCtD
Nefazodone—Pain—Temozolomide—brain cancer	0.000393	0.00136	CcSEcCtD
Nefazodone—Constipation—Temozolomide—brain cancer	0.000393	0.00136	CcSEcCtD
Nefazodone—Feeling abnormal—Carmustine—brain cancer	0.000392	0.00136	CcSEcCtD
Nefazodone—Convulsion—Etoposide—brain cancer	0.000391	0.00136	CcSEcCtD
Nefazodone—Hypertension—Etoposide—brain cancer	0.000389	0.00135	CcSEcCtD
Nefazodone—Dizziness—Hydroxyurea—brain cancer	0.000389	0.00135	CcSEcCtD
Nefazodone—Gastrointestinal pain—Carmustine—brain cancer	0.000389	0.00135	CcSEcCtD
Nefazodone—CYP2D6—central nervous system—brain cancer	0.000389	0.00203	CbGeAlD
Nefazodone—ABCB1—medulla oblongata—brain cancer	0.000387	0.00202	CbGeAlD
Nefazodone—Chest pain—Etoposide—brain cancer	0.000384	0.00133	CcSEcCtD
Nefazodone—CYP2D6—cerebellum—brain cancer	0.00038	0.00199	CbGeAlD
Nefazodone—Discomfort—Etoposide—brain cancer	0.000379	0.00132	CcSEcCtD
Nefazodone—Feeling abnormal—Temozolomide—brain cancer	0.000379	0.00131	CcSEcCtD
Nefazodone—Body temperature increased—Carmustine—brain cancer	0.000376	0.00131	CcSEcCtD
Nefazodone—Abdominal pain—Carmustine—brain cancer	0.000376	0.00131	CcSEcCtD
Nefazodone—Gastrointestinal pain—Temozolomide—brain cancer	0.000376	0.0013	CcSEcCtD
Nefazodone—Vomiting—Hydroxyurea—brain cancer	0.000374	0.0013	CcSEcCtD
Nefazodone—Rash—Hydroxyurea—brain cancer	0.000371	0.00129	CcSEcCtD
Nefazodone—Confusional state—Etoposide—brain cancer	0.000371	0.00129	CcSEcCtD
Nefazodone—Dermatitis—Hydroxyurea—brain cancer	0.000371	0.00129	CcSEcCtD
Nefazodone—Headache—Hydroxyurea—brain cancer	0.000369	0.00128	CcSEcCtD
Nefazodone—Anaphylactic shock—Etoposide—brain cancer	0.000368	0.00128	CcSEcCtD
Nefazodone—Infection—Etoposide—brain cancer	0.000366	0.00127	CcSEcCtD
Nefazodone—Urticaria—Temozolomide—brain cancer	0.000365	0.00127	CcSEcCtD
Nefazodone—Abdominal pain—Temozolomide—brain cancer	0.000364	0.00126	CcSEcCtD
Nefazodone—Body temperature increased—Temozolomide—brain cancer	0.000364	0.00126	CcSEcCtD
Nefazodone—Thrombocytopenia—Etoposide—brain cancer	0.00036	0.00125	CcSEcCtD
Nefazodone—Tachycardia—Etoposide—brain cancer	0.000359	0.00125	CcSEcCtD
Nefazodone—Hyperhidrosis—Etoposide—brain cancer	0.000356	0.00123	CcSEcCtD
Nefazodone—ABCB1—midbrain—brain cancer	0.000354	0.00185	CbGeAlD
Nefazodone—Anorexia—Etoposide—brain cancer	0.000351	0.00122	CcSEcCtD
Nefazodone—Hypersensitivity—Carmustine—brain cancer	0.000351	0.00122	CcSEcCtD
Nefazodone—Nausea—Hydroxyurea—brain cancer	0.00035	0.00121	CcSEcCtD
Nefazodone—ABCB1—spinal cord—brain cancer	0.000345	0.0018	CbGeAlD
Nefazodone—Hypotension—Etoposide—brain cancer	0.000344	0.00119	CcSEcCtD
Nefazodone—Asthenia—Carmustine—brain cancer	0.000341	0.00118	CcSEcCtD
Nefazodone—HTR2A—brain—brain cancer	0.000339	0.00177	CbGeAlD
Nefazodone—Hypersensitivity—Temozolomide—brain cancer	0.000339	0.00118	CcSEcCtD
Nefazodone—Paraesthesia—Etoposide—brain cancer	0.00033	0.00115	CcSEcCtD
Nefazodone—Asthenia—Temozolomide—brain cancer	0.00033	0.00114	CcSEcCtD
Nefazodone—Dyspnoea—Etoposide—brain cancer	0.000328	0.00114	CcSEcCtD
Nefazodone—Somnolence—Etoposide—brain cancer	0.000327	0.00114	CcSEcCtD
Nefazodone—Diarrhoea—Carmustine—brain cancer	0.000326	0.00113	CcSEcCtD
Nefazodone—Pruritus—Temozolomide—brain cancer	0.000325	0.00113	CcSEcCtD
Nefazodone—Decreased appetite—Etoposide—brain cancer	0.00032	0.00111	CcSEcCtD
Nefazodone—Dizziness—Carmustine—brain cancer	0.000315	0.00109	CcSEcCtD
Nefazodone—Pain—Etoposide—brain cancer	0.000315	0.00109	CcSEcCtD
Nefazodone—Constipation—Etoposide—brain cancer	0.000315	0.00109	CcSEcCtD
Nefazodone—Diarrhoea—Temozolomide—brain cancer	0.000315	0.00109	CcSEcCtD
Nefazodone—ABCB1—endocrine gland—brain cancer	0.000311	0.00162	CbGeAlD
Nefazodone—CYP2D6—brain—brain cancer	0.000309	0.00161	CbGeAlD
Nefazodone—ABCB1—head—brain cancer	0.000307	0.0016	CbGeAlD
Nefazodone—Dizziness—Temozolomide—brain cancer	0.000304	0.00106	CcSEcCtD
Nefazodone—Feeling abnormal—Etoposide—brain cancer	0.000303	0.00105	CcSEcCtD
Nefazodone—Vomiting—Carmustine—brain cancer	0.000303	0.00105	CcSEcCtD
Nefazodone—Gastrointestinal pain—Etoposide—brain cancer	0.000301	0.00104	CcSEcCtD
Nefazodone—Rash—Carmustine—brain cancer	0.0003	0.00104	CcSEcCtD
Nefazodone—Dermatitis—Carmustine—brain cancer	0.0003	0.00104	CcSEcCtD
Nefazodone—Headache—Carmustine—brain cancer	0.000298	0.00103	CcSEcCtD
Nefazodone—Vomiting—Temozolomide—brain cancer	0.000292	0.00101	CcSEcCtD
Nefazodone—Urticaria—Etoposide—brain cancer	0.000292	0.00101	CcSEcCtD
Nefazodone—Abdominal pain—Etoposide—brain cancer	0.000291	0.00101	CcSEcCtD
Nefazodone—Body temperature increased—Etoposide—brain cancer	0.000291	0.00101	CcSEcCtD
Nefazodone—Rash—Temozolomide—brain cancer	0.00029	0.00101	CcSEcCtD
Nefazodone—Dermatitis—Temozolomide—brain cancer	0.00029	0.00101	CcSEcCtD
Nefazodone—Headache—Temozolomide—brain cancer	0.000288	0.001	CcSEcCtD
Nefazodone—Nausea—Carmustine—brain cancer	0.000283	0.000981	CcSEcCtD
Nefazodone—ABCB1—central nervous system—brain cancer	0.00028	0.00146	CbGeAlD
Nefazodone—ABCB1—cerebellum—brain cancer	0.000274	0.00143	CbGeAlD
Nefazodone—Nausea—Temozolomide—brain cancer	0.000273	0.000948	CcSEcCtD
Nefazodone—Hypersensitivity—Etoposide—brain cancer	0.000271	0.000941	CcSEcCtD
Nefazodone—Asthenia—Etoposide—brain cancer	0.000264	0.000916	CcSEcCtD
Nefazodone—Pruritus—Etoposide—brain cancer	0.00026	0.000903	CcSEcCtD
Nefazodone—Diarrhoea—Etoposide—brain cancer	0.000252	0.000874	CcSEcCtD
Nefazodone—Dizziness—Etoposide—brain cancer	0.000243	0.000844	CcSEcCtD
Nefazodone—Vomiting—Etoposide—brain cancer	0.000234	0.000812	CcSEcCtD
Nefazodone—Rash—Etoposide—brain cancer	0.000232	0.000805	CcSEcCtD
Nefazodone—Dermatitis—Etoposide—brain cancer	0.000232	0.000804	CcSEcCtD
Nefazodone—Headache—Etoposide—brain cancer	0.000231	0.0008	CcSEcCtD
Nefazodone—ABCB1—brain—brain cancer	0.000222	0.00116	CbGeAlD
Nefazodone—Nausea—Etoposide—brain cancer	0.000219	0.000758	CcSEcCtD
Nefazodone—HTR2C—GPCR downstream signaling—VAV1—brain cancer	3.32e-05	0.000631	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.32e-05	0.00063	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—SHH—brain cancer	3.3e-05	0.000627	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—GLI1—brain cancer	3.27e-05	0.00062	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ABR—brain cancer	3.26e-05	0.00062	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SUFU—brain cancer	3.25e-05	0.000618	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SUFU—brain cancer	3.23e-05	0.000614	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ABR—brain cancer	3.19e-05	0.000607	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—TRPC6—brain cancer	3.18e-05	0.000604	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—VAV1—brain cancer	3.18e-05	0.000604	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GLI2—brain cancer	3.15e-05	0.000599	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—BSG—brain cancer	3.14e-05	0.000597	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—GFAP—brain cancer	3.14e-05	0.000596	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—SMO—brain cancer	3.13e-05	0.000594	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—PTCH1—brain cancer	3.13e-05	0.000594	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—GFAP—brain cancer	3.12e-05	0.000593	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SUFU—brain cancer	3.1e-05	0.000588	CbGpPWpGaD
Nefazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.09e-05	0.000588	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.09e-05	0.000586	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GLI2—brain cancer	3.08e-05	0.000586	CbGpPWpGaD
Nefazodone—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.06e-05	0.000581	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—VAV1—brain cancer	3.03e-05	0.000576	CbGpPWpGaD
Nefazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.03e-05	0.000575	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—VAV1—brain cancer	3.02e-05	0.000573	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—GFAP—brain cancer	2.99e-05	0.000567	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HEY1—brain cancer	2.97e-05	0.000565	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ABR—brain cancer	2.97e-05	0.000564	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GLI1—brain cancer	2.96e-05	0.000563	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HEY1—brain cancer	2.96e-05	0.000562	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ENO2—brain cancer	2.95e-05	0.000561	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—IDH1—brain cancer	2.95e-05	0.00056	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—DLL1—brain cancer	2.92e-05	0.000554	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—DLL1—brain cancer	2.9e-05	0.000551	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GLI1—brain cancer	2.9e-05	0.000551	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—VAV1—brain cancer	2.89e-05	0.000549	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—VAV1—brain cancer	2.88e-05	0.000548	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GLI2—brain cancer	2.87e-05	0.000545	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HEY1—brain cancer	2.83e-05	0.000538	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	2.82e-05	0.000537	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SUFU—brain cancer	2.81e-05	0.000534	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CYP2C9—brain cancer	2.79e-05	0.00053	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—DLL1—brain cancer	2.78e-05	0.000528	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SUFU—brain cancer	2.75e-05	0.000522	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.73e-05	0.000518	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GFAP—brain cancer	2.71e-05	0.000515	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—IDH1—brain cancer	2.7e-05	0.000513	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.7e-05	0.000513	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GLI1—brain cancer	2.69e-05	0.000512	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GFAP—brain cancer	2.65e-05	0.000504	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—PIK3CG—brain cancer	2.64e-05	0.000501	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CYP2C9—brain cancer	2.63e-05	0.000499	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	2.62e-05	0.000499	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—VAV1—brain cancer	2.62e-05	0.000498	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HEY1—brain cancer	2.57e-05	0.000488	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—VAV1—brain cancer	2.56e-05	0.000487	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SUFU—brain cancer	2.55e-05	0.000485	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—DLL1—brain cancer	2.52e-05	0.000479	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HEY1—brain cancer	2.51e-05	0.000478	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SHH—brain cancer	2.48e-05	0.000471	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—DLL1—brain cancer	2.47e-05	0.000469	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SHH—brain cancer	2.47e-05	0.000469	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GFAP—brain cancer	2.46e-05	0.000468	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TRPC6—brain cancer	2.39e-05	0.000454	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—VAV1—brain cancer	2.38e-05	0.000453	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TRPC6—brain cancer	2.38e-05	0.000452	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.38e-05	0.000452	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—BSG—brain cancer	2.37e-05	0.00045	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SHH—brain cancer	2.36e-05	0.000449	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SMO—brain cancer	2.35e-05	0.000447	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PTCH1—brain cancer	2.35e-05	0.000447	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PTCH1—brain cancer	2.34e-05	0.000444	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SMO—brain cancer	2.34e-05	0.000444	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HEY1—brain cancer	2.34e-05	0.000444	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ENO2—brain cancer	2.33e-05	0.000443	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—DLL1—brain cancer	2.29e-05	0.000435	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TRPC6—brain cancer	2.28e-05	0.000433	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SMO—brain cancer	2.24e-05	0.000425	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PTCH1—brain cancer	2.24e-05	0.000425	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—BSG—brain cancer	2.23e-05	0.000424	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.19e-05	0.000416	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SHH—brain cancer	2.14e-05	0.000407	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.14e-05	0.000406	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ENO2—brain cancer	2.14e-05	0.000406	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	2.12e-05	0.000403	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	2.11e-05	0.000401	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SHH—brain cancer	2.1e-05	0.000398	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TRPC6—brain cancer	2.06e-05	0.000392	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—IDH1—brain cancer	2.04e-05	0.000387	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PTCH1—brain cancer	2.03e-05	0.000386	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SMO—brain cancer	2.03e-05	0.000386	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TRPC6—brain cancer	2.02e-05	0.000384	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	2.02e-05	0.000384	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PTCH1—brain cancer	1.99e-05	0.000378	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SMO—brain cancer	1.99e-05	0.000378	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SHH—brain cancer	1.95e-05	0.00037	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	1.92e-05	0.000366	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—IDH1—brain cancer	1.92e-05	0.000365	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	1.91e-05	0.000364	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TRPC6—brain cancer	1.88e-05	0.000357	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOTCH2—brain cancer	1.88e-05	0.000357	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOTCH2—brain cancer	1.87e-05	0.000355	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—IL2—brain cancer	1.86e-05	0.000353	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SMO—brain cancer	1.85e-05	0.000351	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PTCH1—brain cancer	1.85e-05	0.000351	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	1.83e-05	0.000348	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	1.83e-05	0.000348	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.8e-05	0.000341	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	1.79e-05	0.000341	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VAV1—brain cancer	1.79e-05	0.00034	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	1.79e-05	0.00034	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VAV1—brain cancer	1.78e-05	0.000339	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP2C9—brain cancer	1.72e-05	0.000326	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VAV1—brain cancer	1.71e-05	0.000324	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.67e-05	0.000317	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	1.66e-05	0.000316	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.63e-05	0.000309	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.62e-05	0.000308	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ENO2—brain cancer	1.61e-05	0.000306	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.59e-05	0.000302	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—VEGFA—brain cancer	1.58e-05	0.0003	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VAV1—brain cancer	1.55e-05	0.000294	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HES1—brain cancer	1.54e-05	0.000293	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HES1—brain cancer	1.53e-05	0.000291	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ENO2—brain cancer	1.52e-05	0.000288	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.51e-05	0.000288	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.51e-05	0.000287	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.49e-05	0.000283	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.48e-05	0.000282	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.48e-05	0.000281	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HES1—brain cancer	1.47e-05	0.000279	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.47e-05	0.000279	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—BSG—brain cancer	1.46e-05	0.000277	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.46e-05	0.000277	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SPP1—brain cancer	1.42e-05	0.000271	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—IL2—brain cancer	1.42e-05	0.00027	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SPP1—brain cancer	1.42e-05	0.000269	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.41e-05	0.000267	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	1.4e-05	0.000265	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SPP1—brain cancer	1.36e-05	0.000258	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PIK3CG—brain cancer	1.35e-05	0.000257	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL2—brain cancer	1.35e-05	0.000257	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2—brain cancer	1.35e-05	0.000256	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HES1—brain cancer	1.33e-05	0.000253	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HES1—brain cancer	1.3e-05	0.000248	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2—brain cancer	1.29e-05	0.000245	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.29e-05	0.000245	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IRS2—brain cancer	1.29e-05	0.000245	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IRS2—brain cancer	1.28e-05	0.000243	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.27e-05	0.000241	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.26e-05	0.00024	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—IDH1—brain cancer	1.26e-05	0.000239	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.24e-05	0.000236	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SPP1—brain cancer	1.23e-05	0.000234	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IRS2—brain cancer	1.23e-05	0.000233	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HES1—brain cancer	1.21e-05	0.00023	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.2e-05	0.000229	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TP53—brain cancer	1.19e-05	0.000226	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.17e-05	0.000223	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2—brain cancer	1.17e-05	0.000222	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.15e-05	0.000219	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.15e-05	0.000218	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.14e-05	0.000216	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—APC—brain cancer	1.14e-05	0.000216	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—APC—brain cancer	1.13e-05	0.000215	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.13e-05	0.000215	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.12e-05	0.000213	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IRS2—brain cancer	1.11e-05	0.000211	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.09e-05	0.000207	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—APC—brain cancer	1.08e-05	0.000206	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	1.08e-05	0.000206	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PIK3CG—brain cancer	1.07e-05	0.000203	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.06e-05	0.000202	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.04e-05	0.000197	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.03e-05	0.000196	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.01e-05	0.000192	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ENO2—brain cancer	9.93e-06	0.000189	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—EGFR—brain cancer	9.87e-06	0.000187	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PIK3CG—brain cancer	9.82e-06	0.000187	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—APC—brain cancer	9.82e-06	0.000187	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PIK3CG—brain cancer	9.79e-06	0.000186	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—APC—brain cancer	9.62e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	9.62e-06	0.000183	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—EGFR—brain cancer	8.95e-06	0.00017	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—APC—brain cancer	8.94e-06	0.00017	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	8.94e-06	0.00017	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RELA—brain cancer	8.88e-06	0.000169	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RELA—brain cancer	8.84e-06	0.000168	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—ERBB2—brain cancer	8.83e-06	0.000168	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—ERBB2—brain cancer	8.78e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—EGFR—brain cancer	8.76e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RELA—brain cancer	8.46e-06	0.000161	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ERBB2—brain cancer	8.41e-06	0.00016	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—EGFR—brain cancer	8.14e-06	0.000155	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2—brain cancer	8e-06	0.000152	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2—brain cancer	7.96e-06	0.000151	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCND1—brain cancer	7.8e-06	0.000148	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCND1—brain cancer	7.76e-06	0.000147	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CTNNB1—brain cancer	7.72e-06	0.000147	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CTNNB1—brain cancer	7.69e-06	0.000146	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RELA—brain cancer	7.68e-06	0.000146	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ERBB2—brain cancer	7.63e-06	0.000145	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2—brain cancer	7.62e-06	0.000145	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RELA—brain cancer	7.52e-06	0.000143	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ERBB2—brain cancer	7.47e-06	0.000142	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCND1—brain cancer	7.43e-06	0.000141	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PIK3CG—brain cancer	7.39e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	7.36e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RELA—brain cancer	6.98e-06	0.000133	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PIK3CG—brain cancer	6.96e-06	0.000132	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ERBB2—brain cancer	6.94e-06	0.000132	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2—brain cancer	6.91e-06	0.000131	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VEGFA—brain cancer	6.8e-06	0.000129	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2—brain cancer	6.77e-06	0.000129	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VEGFA—brain cancer	6.77e-06	0.000129	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCND1—brain cancer	6.74e-06	0.000128	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—STAT3—brain cancer	6.73e-06	0.000128	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—STAT3—brain cancer	6.7e-06	0.000127	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CTNNB1—brain cancer	6.67e-06	0.000127	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCND1—brain cancer	6.6e-06	0.000125	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	6.53e-06	0.000124	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VEGFA—brain cancer	6.48e-06	0.000123	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—STAT3—brain cancer	6.41e-06	0.000122	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2—brain cancer	6.29e-06	0.00012	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MYC—brain cancer	6.26e-06	0.000119	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MYC—brain cancer	6.22e-06	0.000118	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCND1—brain cancer	6.13e-06	0.000117	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—EGFR—brain cancer	6.12e-06	0.000116	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—EGFR—brain cancer	6.09e-06	0.000116	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	6.07e-06	0.000115	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MYC—brain cancer	5.96e-06	0.000113	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VEGFA—brain cancer	5.87e-06	0.000112	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—EGFR—brain cancer	5.83e-06	0.000111	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—STAT3—brain cancer	5.82e-06	0.000111	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VEGFA—brain cancer	5.75e-06	0.000109	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—STAT3—brain cancer	5.7e-06	0.000108	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MYC—brain cancer	5.41e-06	0.000103	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VEGFA—brain cancer	5.34e-06	0.000102	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MYC—brain cancer	5.29e-06	0.000101	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—STAT3—brain cancer	5.29e-06	0.000101	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EGFR—brain cancer	5.29e-06	0.0001	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EGFR—brain cancer	5.18e-06	9.84e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TP53—brain cancer	5.14e-06	9.76e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TP53—brain cancer	5.11e-06	9.71e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MYC—brain cancer	4.92e-06	9.34e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TP53—brain cancer	4.89e-06	9.3e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EGFR—brain cancer	4.81e-06	9.14e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PIK3CG—brain cancer	4.55e-06	8.65e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TP53—brain cancer	4.44e-06	8.44e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TP53—brain cancer	4.35e-06	8.26e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TP53—brain cancer	4.04e-06	7.67e-05	CbGpPWpGaD
